Cargando…
Multiple Sclerosis and CNS Inflammatory Disorders.
Multiple Sclerosis and CNS Inflammatory Disorders is a practical guide to effective care of patients with multiple sclerosis and other neuroimmunologic and CNS inflammatory disorders. It provides the scientific basis of multiple sclerosis including etiology, epidemiology, and pathogenesis. It covers...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
Wiley,
2014.
|
| Colección: | NIP- Neurology in Practice.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Multiple Sclerosis and CNS Inflammatory Disorders; Copyright; Contents; Contributors ; Series Foreword ; Preface; 1 Etiology ; Background; Genes; Gender effects: Genetic or biologic?; The role of the environment; Environmental MS risk factors: The major players; Vitamin D; Infection; Smoking; Combining risk factors; Conclusion; Acknowledgment; References; 2 Immunopathogenesis of Multiple Sclerosis ; What does the neuropathology of MS tell us about its pathogenesis?; Gray matter pathology; Multiple sclerosis as an autoimmune disease; Candidates for the self-antigen in multiple sclerosis.
- Antigen spreadingEpitope spreading; Outside-in versus inside-out?; Lymphocyte trafficking into the CNS ; Role of T cells in MS ; Role of B cells and humoral immunity; Role of microglia and macrophages; Role of other cells: Dendritic cells and astrocytes; Role of cytokines; What might trigger autoimmunity?; Further Reading; 3 Diagnostic Process ; Introduction; Clinical features of MS ; Defining MS; MS disease courses; Common symptoms in MS ; Diagnostic evaluation of MS ; MRI; Revised McDonald criteria for diagnosis of MS ; Ancillary testing in the diagnosis of MS.
- Differential diagnosis of MS Conclusion; Further Reading; 4 MRI in Diagnosis and Disease Monitoring ; Introduction; MRI at presentation; Lesions; Brain atrophy; Spinal cord; MRI diagnostic criteria; MRI consensus protocol; MRI for monitoring disease and treatment; New lesion activity; Brain atrophy; Limitations; Nonconventional MRI; Magnetization transfer imaging; Magnetic resonance spectroscopy; Susceptibility-weighted imaging; Diffusion-weighted imaging; Perfusion-weighted imaging; Conclusions; Acknowledgments; References; 5 Relapsing MS: Disease Staging and Therapeutic Algorithms.
- IntroductionWindow; Prognostic factors; Therapy; Initiation; Early window; Late window; Suboptimal response; Intolerance: Lateral therapy; Mild breakthrough: Lateral therapy; Major breakthrough; Combination therapy; Rescue therapy; Escalation; Rapid advancement; Conclusion; Newer oral agents; Further Reading; 6 Progressive MS Treatment Algorithms ; Background; Challenges to clinical trials in progressive MS ; Clinical trials in progressive MS ; Interferon-beta; Glatiramer acetate; Mitoxantrone; Cyclophosphamide; Methotrexate; Methylprednisolone; Other disease-modifying therapies.
- Monitoring progressive MS in clinical practiceTreatment of progressive MS in clinical practice; Stopping disease-modifying therapy; Neuroprotective strategies; Other treatment considerations; Further Reading; 7 Sex-Determined Issues in Multiple Sclerosis ; Epidemiology of MS and gender; Basic science of sex hormone and chromosome differences seen in MS ; Actions of sex hormones; Gender effects seen in genetics of MS ; Reproductive issues in MS ; Menstrual cycle and menopause; Effects on fertility; Contraceptive issues; Congenital effects; Pregnancy and the MS patient; Epidemiology.